Apollo Hospitals Enterprise Limited

Healthcare›Healthcare›Healthcare Services›Hospital

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹8826.00
Market cap
1,26,877 Cr
Stock P/E
61.1
P/B
12.72
Dividend yield
0.2%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales4,418 Cr4,847 Cr4,851 Cr4,944 Cr5,086 Cr5,589 Cr5,527 Cr5,592 Cr5,842 Cr6,304 Cr6,477 Cr6,606 Cr
Operating expenses (approx.)3,909 Cr4,219 Cr4,237 Cr4,303 Cr4,411 Cr4,774 Cr4,765 Cr4,823 Cr4,990 Cr5,362 Cr5,512 Cr5,595 Cr
EBITDA509 Cr628 Cr614 Cr641 Cr675 Cr816 Cr762 Cr770 Cr852 Cr941 Cr965 Cr1,011 Cr
OPM %11.5%12.9%12.7%13.0%13.3%14.6%13.8%13.8%14.6%14.9%14.9%15.3%
Other income28 Cr22 Cr28 Cr28 Cr37 Cr38 Cr64 Cr61 Cr40 Cr55 Cr53 Cr44 Cr
Interest106 Cr111 Cr113 Cr119 Cr116 Cr118 Cr110 Cr115 Cr108 Cr110 Cr113 Cr119 Cr
Depreciation167 Cr163 Cr167 Cr190 Cr177 Cr185 Cr185 Cr211 Cr215 Cr218 Cr219 Cr224 Cr
Profit before tax264 Cr377 Cr362 Cr360 Cr419 Cr552 Cr531 Cr505 Cr569 Cr668 Cr667 Cr711 Cr
Tax %36.6%34.5%30.1%30.5%27.4%29.3%29.5%20.0%24.9%27.0%24.8%23.9%
Net profit173 Cr249 Cr254 Cr258 Cr316 Cr396 Cr379 Cr415 Cr441 Cr494 Cr516 Cr551 Cr
EPS (₹)₹11.59₹16.20₹17.06₹17.65₹21.23₹26.34₹25.89₹27.10₹30.10₹33.19₹34.94₹36.82

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Standalone onlyMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales9,617 Cr11,247 Cr10,560 Cr14,663 Cr16,612 Cr19,059 Cr21,794 Cr25,229 CrSign in for TTM
Operating expenses (approx.)8,554 Cr9,660 Cr9,423 Cr12,478 Cr14,563 Cr16,669 Cr18,772 Cr21,459 CrSign in for TTM
EBITDA1,064 Cr1,587 Cr1,137 Cr2,185 Cr2,050 Cr2,391 Cr3,022 Cr3,769 CrSign in for TTM
OPM %11.1%14.1%10.8%14.9%12.3%12.5%13.9%14.9%Sign in for TTM
Other income31 Cr27 Cr45 Cr78 Cr90 Cr106 Cr200 Cr192 CrSign in for TTM
Interest327 Cr533 Cr449 Cr379 Cr381 Cr449 Cr459 Cr450 CrSign in for TTM
Depreciation396 Cr620 Cr573 Cr601 Cr615 Cr687 Cr758 Cr876 CrSign in for TTM
Profit before tax373 Cr660 Cr221 Cr1,578 Cr1,144 Cr1,363 Cr2,006 Cr2,616 CrSign in for TTM
Tax %46.5%34.1%38.4%30.2%22.4%32.7%26.6%25.2%Sign in for TTM
Net profit200 Cr432 Cr137 Cr1,108 Cr845 Cr935 Cr1,505 Cr2,003 CrSign in for TTM
EPS (₹)₹16.97₹32.70₹10.74₹73.42₹56.97₹62.50₹100.56₹135.04Sign in for TTM
Dividend payout %———3.9%30.5%23.6%18.5%14.6%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Standalone onlyMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital70 Cr70 Cr70 Cr72 Cr72 Cr72 Cr72 Cr72 Cr
Reserves3,256 Cr3,262 Cr3,262 Cr5,565 Cr6,125 Cr6,864 Cr8,140 Cr9,408 Cr
Borrowings————2,710 Cr3,162 Cr5,275 Cr5,659 Cr
Other liabilities4,545 Cr8,007 Cr8,086 Cr7,577 Cr5,186 Cr6,271 Cr6,729 Cr6,564 Cr
Total liabilities8,428 Cr11,338 Cr11,417 Cr13,214 Cr14,428 Cr16,753 Cr20,657 Cr22,197 Cr
Fixed assets (net)————7,432 Cr8,541 Cr9,816 Cr11,039 Cr
CWIP————602 Cr845 Cr771 Cr992 Cr
Investments————574 Cr986 Cr2,487 Cr2,179 Cr
Other assets————4,343 Cr5,285 Cr7,034 Cr6,902 Cr
Total assets8,428 Cr11,338 Cr11,417 Cr13,214 Cr14,428 Cr16,753 Cr20,657 Cr22,197 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Standalone onlyMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———1,616 Cr1,377 Cr1,920 Cr2,136 Cr2,856 Cr
Cash from investing———-791 Cr-857 Cr-1,537 Cr-3,381 Cr-2,148 Cr
Cash from financing———-768 Cr-633 Cr-311 Cr1,317 Cr-478 Cr
Net cash flow———57 Cr-113 Cr72 Cr73 Cr230 Cr
Free cash flow (OCF − Capex)———958 Cr249 Cr784 Cr424 Cr894 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019Standalone onlyMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %20.1%29.0%16.9%28.1%15.5%16.3%16.3%18.5%
ROE %7.1%13.7%4.5%18.7%12.5%12.3%16.7%19.5%
Debtor days————49485050
Inventory days————62686465
Days payable————305352296270
Cash conversion cycle————-194-236-182-154
Debt / equity0.010.00——0.440.460.640.60
Current ratio————1.301.131.541.06
Net debt / EBITDA0.000.000.000.001.111.111.551.29

Compare with peers

Loading peers…